Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Lung Cancer

Free Subscription 08.12.2025 2 Ann Surg Oncol 10 Anticancer Res 1 Arch Bronconeumol 3 BMC Cancer 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Res 3 Cancer Sci 1 Clin Lung Cancer 2 Eur J Cancer 1 Eur J Cardiothorac Surg 1 Hum Pathol 1 J Cancer Res Clin Oncol 1 J Clin Oncol 1 J Thorac Cardiovasc Surg 2 Lung Cancer 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. MIZOTA K, Kinoshita F, Takenaka T, Yoshizumi T, et al
   ASO Author Reflections: The Emerging Role of the CALLY Index in Surgically Resected Non-Small-Cell Lung Cancer.
   Ann Surg Oncol. 2025 Dec 4. doi: 10.1245/s10434-025-18824.
   PubMed        
   
   
2. LIU C, Liao Y, Wang D, Yang J, et al
   Machine Learning for Classification in Lung Cancer Using Routine Clinical and Laboratory Data.
   Ann Surg Oncol. 2025 Dec 3. doi: 10.1245/s10434-025-18747.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. CHECK JH, Check DL, Wilson C
   Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone.
   Anticancer Res. 2025;45:5785-5798.
   PubMed         Abstract available
   
   
4. KREJCI D, Subrt A, Opalka P, Krejci J, et al
   Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer.
   Anticancer Res. 2025;45:5579-5586.
   PubMed         Abstract available
   
   
5. AHMED F, Khan S
   Potential Role of Tumor-derived MIF in B-Cell Antigen Presentation in Lung Adenocarcinoma: Single-cell and TCGA Analyses.
   Anticancer Res. 2025;45:5369-5387.
   PubMed         Abstract available
   
   
6. LUO RG, Xie XB, Zhang YY, He YQ, et al
   Ibrutinib Inhibits Tumor Progression, Alleviates Pain, and Protects the Tibia in a Bone Metastasis Model of Lung Cancer.
   Anticancer Res. 2025;45:5477-5490.
   PubMed         Abstract available
   
   
7. YASUURA Y, Woo T, Tanaka S, Masuda H, et al
   Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non-small Cell Lung Cancer.
   Anticancer Res. 2025;45:5655-5666.
   PubMed         Abstract available
   
   
8. AMANO Y, Tanino R, Sun R, Tsubata Y, et al
   Inhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus.
   Anticancer Res. 2025;45:5287-5297.
   PubMed         Abstract available
   
   
9. LEE WY, Tung SL, Chuang SE, Lin SC, et al
   AXL Transcriptionally Up-regulates ISG15 Expression to Mediate Cell Proliferation in Non-small-cell Lung Cancer Cells.
   Anticancer Res. 2025;45:5445-5455.
   PubMed         Abstract available
   
   
10. NAGASAKI Y, Yamane H, Takeyama M, Ochi N, et al
    Co-expression of PD1/PD-L1 on Tumor Cells Is Involved in the Regulation of Cell Proliferation.
    Anticancer Res. 2025;45:5341-5350.
    PubMed         Abstract available
    
    
11. TAKAHARA Y, Abe R, Nagae S, Tanaka T, et al
    Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Anticancer Res. 2025;45:5633-5644.
    PubMed         Abstract available
    
    
12. ASANO Y, Han Q, Li S, Mizuta K, et al
    Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts.
    Anticancer Res. 2025;45:5389-5398.
    PubMed         Abstract available
    
    

    
    Arch Bronconeumol

13. ORDONEZ GOMEZ P, Minana MD, Garcia-Ballesteros C, Signes-Costa J, et al
    Immune Gene Polymorphisms and Lung Cancer Risk in Chronic Obstructive Pulmonary Disease with Emphysema.
    Arch Bronconeumol. 2025 Nov 4:S0300-2896(25)00388.
    PubMed        
    
    

    
    BMC Cancer

14. LI Q, Liu R, Han L, Xu Y, et al
    Analysis of setup error and setup efficiency in SBRT for non-small cell lung cancer via a surface-guided radiation therapy system.
    BMC Cancer. 2025 Dec 1. doi: 10.1186/s12885-025-15353.
    PubMed         Abstract available
    
    
15. ZHANG X, Li W, Du Y, Zhang Y, et al
    A novel nomogram based on DLL3 and PD-L1 for predicting the prognosis of patients with small cell lung cancer.
    BMC Cancer. 2025;25:1848.
    PubMed         Abstract available
    
    
16. BUGDAY I, Inanc M, Ozkan M, Bozkurt O, et al
    Prognostic role of prognostic nutritional index change in patients with extensive stage small cell lung cancer treated with platinum-based chemotherapy.
    BMC Cancer. 2025;25:1846.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

17. JIN J, Rahmatallah Y, Gomez-Acevedo H, Park YM, et al
    A Tracts of Homozygosity Approach Identifies Methylation-Regulated CSMD1 Expression Targets in Non-Small Cell Lung Cancers Related to Smoking Behavior.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2247-2258.
    PubMed         Abstract available
    
    

    
    Cancer Res

18. YASSEEN BA, DeNicola GM
    Can't KEEP Up: UXS1 Dependency Exposes a Pyrimidine Vulnerability in KEAP1-Mutant Lung Cancer.
    Cancer Res. 2025;85:4582-4584.
    PubMed         Abstract available
    
    
19. LIU T, Huang S, Li Z, Li J, et al
    Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR-Mutant Lung Cancer.
    Cancer Res. 2025 Dec 2. doi: 10.1158/0008-5472.CAN-25-0433.
    PubMed         Abstract available
    
    

    
    Cancer Sci

20. LIU SY, Lin LT, Chang CH, Chen YJ, et al
    Liposomal (188)Rhenium Plus Macrophage Depletion Enhances Anti-PD-L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer.
    Cancer Sci. 2025;116:3442-3458.
    PubMed         Abstract available
    
    
21. TOZUKA T, Noro R, Naito Y, Miura N, et al
    ACTN4 Gene Amplification and Actinin-4 Protein Expression for Osimertinib Efficacy in EGFR-Mutant NSCLC.
    Cancer Sci. 2025;116:3367-3375.
    PubMed         Abstract available
    
    
22. JIANG Y, Liang Q, Zhu Y, Liang X, et al
    Third-Generation EGFR-TKIs Combined With Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Real-World Study.
    Cancer Sci. 2025 Nov 28. doi: 10.1111/cas.70269.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

23. CATLI MM, Onder AH
    Re: "Changing Lung Cancer Resection Outcomes Over Two Decades".
    Clin Lung Cancer. 2025;27:53-54.
    PubMed        
    
    

    
    Eur J Cancer

24. SONG Z, Li Z, Zhang Y, Wang P, et al
    Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
    Eur J Cancer. 2025;232:116153.
    PubMed         Abstract available
    
    
25. JIANG B, Lancaster HL, Davies MPA, Gratama JC, et al
    AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation.
    Eur J Cancer. 2025;232:116137.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

26. YUAN W, Huang Q, Yan X, Xu G, et al
    Prognostic significance of the controlling nutritional status score in non-small cell lung cancer patients undergoing neoadjuvant therapy: Development of a predictive nomogram.
    Eur J Cardiothorac Surg. 2025 Dec 3:ezaf436. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Hum Pathol

27. WU J, Lin X, Li D, Tong G, et al
    Histomorphological and molecular spectrum of ciliated muconodular papillary tumors with implication for malignant potential: Insights from a literature review and series report.
    Hum Pathol. 2025;166:105981.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

28. KASTNER A, Hampf C, Naumann P, Fiedler-Lacombe L, et al
    Concept and feasibility of privacy-preserving record linkage of cancer registry data and claims data in Germany: results from the DigiNet study on stage IV non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2025;152:6.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

29. TOMASINI P, Wang Y, Li Y, Felip E, et al
    Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.
    J Clin Oncol. 2025 Dec 1:JCO2402835. doi: 10.1200/JCO-24-02835.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

30. FUKAMI T, Hamada A, Suda K, Kaida H, et al
    Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective study.
    J Thorac Cardiovasc Surg. 2025;170:1784-1794.
    PubMed         Abstract available
    
    

    
    Lung Cancer

31. LE H, Coulter J, Culver K, Cappelleri JC, et al
    Patient and oncologist preferences for ALK+ advanced non-small cell lung cancer tyrosine kinase inhibitor treatments: a discrete choice experiment in the United States.
    Lung Cancer. 2025;211:108850.
    PubMed         Abstract available
    
    
32. LU S, Fan Y, Dong X, Yu Y, et al
    Entrectinib in Asian patients with ROS1 fusion-positive non-small cell lung cancer: updated efficacy and safety analysis.
    Lung Cancer. 2025;211:108851.
    PubMed         Abstract available
    
    

    
    PLoS One

33. PAEZ R, Ratwani AP, Duke JD, Bridwell G, et al
    Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial.
    PLoS One. 2025;20:e0327611.
    PubMed         Abstract available
    
    
34. HAN MTT, Oo TZM, Chewaskulyong B, Pornprasert S, et al
    MiR-125b-5p and miR-100-5p as Biomarkers and therapeutic targets for the prevention of particulate matter-induced non-smoker lung cancer.
    PLoS One. 2025;20:e0337805.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.